BTOG
banner
btog.bsky.social
BTOG
@btog.bsky.social
British Thoracic Oncology Group (BTOG) - multi-disciplinary group for professionals involved with thoracic malignancies.
Early detection saves lives. Screening, research and collaboration are key to tackling lung cancer. BTOG is committed to advancing knowledge and improving care across the UK.
#LungCancerAwareness #LCSM #LungCancer
November 10, 2025 at 9:00 AM
⏳ 1 week to go!
We’re nearly there — a full day on non-smoking lung cancer: from diagnosis to survivorship. With @ruthstraussfdn.bsky.social
Still time to register 👉
🔗 www.btog.org/non-smo...
📅 Thurs 13 Nov | 📍 London
#LungCancer #LCSM #NonSmokingLungCancer
November 6, 2025 at 10:00 AM
Just out: ESMO Top 10 Abstracts Webcast & Podcast

The rationale and design, efficacy, side effects & potential impact with: @tnewsomdavis.bsky.social Dr Shobhit Baijal & Dr Sharmistha Ghosh.

Video webcast is members only, audio podcast open access.

Details: www.btog.org/esmo25-top10-webcast/
November 5, 2025 at 12:21 PM
💭 What’s in a name?
Martin Forster opens the event exploring how we label non-smoking lung cancer — and why it matters.
📅 Join us 13 Nov, London
🔗 www.btog.org/non-smo...

#Oncology #LungCancer
October 30, 2025 at 10:00 AM
New #podcast release:

BTOG does … Chemo RT: What to do in unresectable disease

Dr Emma O'Dowd talks to Dr Clive Peedell, Consultant Clinical Oncologist, James Cook University Hospital.

Search BTOG in App Store/Spotify/Amazon Music or listen via BTOG website www.btog.org/btog-po...

#LCSM
October 29, 2025 at 1:00 PM
✅ CPD credits (applied for)
✅ Patient voice
✅ Groundbreaking science
🎟️ Join the BTOG Non-Smoking Lung Cancer Essential Update with @ruthstraussfdn.bsky.social
📅 13 Nov, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
October 23, 2025 at 9:00 AM
BTOG wishes to inform members of a new @nicecomms.bsky.social release published today.

NICE has recommended Lorlatinib as an option for ALK-positive advanced non-small-cell lung cancer in adults who have not had an ALK inhibitor.

More details
www.nice.org.uk/guidance/TA1...

#LCSM #LungCancer
Overview | Lorlatinib for ALK-positive advanced non-small-cell lung cancer that has not been treated with an ALK inhibitor | Guidance | NICE
www.nice.org.uk
October 21, 2025 at 12:25 PM
👥 Meet the experts:
🧑‍⚕️ @tnewsomdavis.bsky.social
🧑‍⚕️ Martin Forster
and many more with @ruthstraussfdn.bsky.social at #NonSmokingLungCancer.
A full day of learning and networking awaits.
📆 13 Nov
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
October 16, 2025 at 9:00 AM
Screening Event
🎉 Today’s the day!
The #BTOGScreeningEvent kicks off in London with vital updates on #LungCancer screening across the UK.
We’ll be talking strategy, challenges, and the future of screening.
Follow along and join the conversation ⬇️ #BTOGScreeningEvent
#LCSM
October 14, 2025 at 6:00 AM
Reposted by BTOG
The October NLCA newsletter is out now! Read about our QI intervention, upcoming State of the Nation report and more…!
www.natcan.org.uk/news/nlca-ne...

@hqip.bsky.social @btog.bsky.social
#LungCancer
NLCA Newsletter, October 2025 - National Cancer Audit Collaborating Centre
We use some essential cookies to make this website work.
www.natcan.org.uk
October 6, 2025 at 8:53 AM
Reposted by BTOG
The NLCA October quarterly data dashboard is now live! This includes the latest English data up to 31 Dec 2024:
rcs-ceu.shinyapps.io/NLCA/

@hqip.bsky.social @btog.bsky.social #LungCancer
rcs-ceu.shinyapps.io
October 9, 2025 at 9:30 AM
We’re ready. Are you?
👥 Meet national experts
🧠 Debate real-world screening issues
🗣️ Submit your questions live
📍London | ⏰ Doors open 08:30
See you tomorrow at the #BTOGScreeningEvent
#LungCancer #LCSM
October 13, 2025 at 9:00 AM
💡 Discover the latest in mutation-driven lung cancer research.
Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together.
📅 13 Nov | 📍 The View, London
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
October 9, 2025 at 9:00 AM
1 week to go!
⏳ The #BTOGScreeningEvent is almost here. Join the lung cancer screening community in London for vital updates, peer discussions, and practical challenges.
Don’t miss it — register today: www.btog.org/btog-sc...
#LungCancer #LCSM
October 7, 2025 at 9:00 AM
"🧩 Local Consolidative Therapy – survival benefits or overtreatment?
Hear from experts tackling difficult questions in non-smoking lung cancer.
🎫 Register today
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer
With @RuthStraussFdn"
October 2, 2025 at 9:47 AM
Registration and abstract submissions are now open for #BTOG26 our 24th Annual Conference, which will be held at the EICC in Edinburgh.

Full details are on the website www.btog.org/24th-btog-an...

#LCSM #lungcancer
October 1, 2025 at 11:31 AM
Reposted by BTOG
Ruth Strauss Foundation have grants up to £50,000 available for research into Non-Smoking #LungCancer; to improve understanding, diagnosis & quality of life 🫁

🗓️ Apply by 10 Jan 2026 #LCSM

ruthstraussfoundation.com/grants-progr...
September 29, 2025 at 5:26 PM
Reposted by BTOG
♟️ CheckMate for perioperative nivolumab? Dr. Jonathan Spicer presented the latest data from the CheckMate 77T trial at #WCLC25.

🔗 Read more in ILCN: bit.ly/46m612v
Perioperative Nivolumab Proves Safe, Effective for Patients with Resectable Early-Stage NSCLC - ILCN.org (ILCN/WCLC)
Dr. Jonathan Spicer shared patient-reported outcomes data from CheckMate 77T showing the regimen is both safe and tolerable for patients.
bit.ly
September 29, 2025 at 2:32 PM
"Psychological distress in screening is real.
How can we recognise & manage it effectively?
Join the discussion at #BTOGScreeningEvent
✅ Full programme: www.btog.org/btog-sc...
#LungCancer #LCSM
"
September 30, 2025 at 1:11 PM
"🔍 Brain metastases + the DVLA – treatment implications for your practice.
Don’t miss this timely session in our Advanced Disease module.
📍 London | 📅 13 Nov
#LungCancer #LCSM #NonSmokingLungCancer
🔗 www.btog.org/non-smo...
with @RuthStraussFdn"
September 25, 2025 at 1:38 PM
"Peer support is vital in lung cancer screening delivery.
Our fireside chat will feature first-hand insights from teams on the ground — with real-world Q&A from attendees.
🗓️ 14 Oct 2025 | 💬 Bring your questions!
#LungCancer #LCSM #BTOGScreeningEvent
"
September 23, 2025 at 8:54 AM
"🧠 MRD: Molecular Residual Disease – is it ready for clinical use in early NSCLC?
Get the latest on 13 Nov with @RuthStraussFdn.
🔗 www.btog.org/non-smo...
#LungCancer #LCSM #NonSmokingLungCancer"
September 18, 2025 at 5:38 PM
New Podcast Alert!

BTOG does … Neo-adjuvant / peri-operative chemoimmunotherapy

@tnewsomdavis.bsky.social & Emma O'Dowd talk to Jason Adhikaree.

Subscribe via Apple App Store, Spotify or Amazon Music – just search BTOG or listen via the BTOG website.
www.btog.org/btog-podcasts/
#LCSM #lungcancer
September 17, 2025 at 2:02 PM
"Just 4 weeks to go!
Ready to debate hot topics in #LungCancer screening?
Our quick-fire debate session features rapid PRO/CON talks on controversial issues — don’t miss it.
Register now 👉 www.btog.org/btog-sc...
#LCSM #BTOGScreeningEvent
"
September 16, 2025 at 3:27 PM
BTOG wishes to inform members of a new NICE release that has been published today.

NICE has recommended Durvalumab, within its marketing authorisation, as an option to treat limited-stage small-cell lung cancer that has not progressed after platinum-based chemoradiotherapy in adults.
#LCSM
September 16, 2025 at 1:15 PM